Worldwide, people acquire more than 1 million curable sexually transmitted infections (STIs) every day. Based on prevalence data from 2009 to 2016, in 2019, WHO published estimates of new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis, showing total estimated incident cases of 376.4 million ...
Direct maternal infections around the time of childbirth account for about one tenth of
the global burden of maternal death. Women who develop peripartum infections are also
prone to severe morbidity, long-term disabilities such as chronic pelvic pain, fallopian tube
blockage and secondary infertility. M...
Since 2007, the guideline development process within the World Health Organization (WHO) has
been overseen by the WHO Guidelines Review Committee (GRC), which follows internationally
recognized standards such as the GRADE (Grading of Recommendations Assessment, Development
and Evaluation) approach, to su...
About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’...
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve the ...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrea/tratamiento farmacológico,
Farmacorresistencia Microbiana,
Cefixima/administración & dosificación,
Espectinomicina/administración & dosificación,
Ceftriaxona/administración & dosificación,
Gentamicinas/administración & dosificación,
Kanamicina/administración & dosificación,
Tetraciclina/administración & dosificación,
Eritromicina/administración & dosificación,
Povidona Yodada/administración & dosificación,
Nitrato de Plata/administración & dosificación,
Cloranfenicol/uso terapéutico,
Antibacterianos/administración & dosificación,
Quimioterapia Combinada
Infections are responsible for about one fifth of the world’s annual 2.7 million neonatal deaths. In South Asia and sub-Saharan Africa about one quarter of all neonatal deaths are due to infections. Many sick infants only have non-specific signs, and thus are not recognized to have infection. Even when...
Dans le but d’accroître le nombre d’enfants ayant accès au traitement adapté, la classification et le guide thérapeutique simplifiés de l’OMS pour la prise en charge de la pneumonie de l’enfant dans les établissements de santé de premier niveau et les services de consultation ambulatoire o...
